Work

UCHL5 promotes ALK5 liquid-liquid phase separation to drive triple-negative breast cancer progression by suppressing autophagy -dependent ferroptosis

Year: 2026
Type: article
Abstract: Triple-negative breast cancer (TNBC) lacks therapeutic targets and has poor prognosis, creating a need for new molecular targets. We combined bioinformatics analysis of TNBC datasets with experimental validation. Techniques included gain- and loss-of-function studies, autophagy and ferroptosis assays, co-immunoprecipitation, and ubiquitination analysis. A ZIF-8-based nanoplatform co-loaded with UCHL5-IN-1 and 1,6-HD was developed and tested in vitro and in vivo. UCHL5 was overexpressed in TNBC and linked to poor survival. UCHL5 deubiquitinated and stabilized ALK5, promoting its liquid-liquid phase separation (LLPS). ALK5 condensates activated the ALK5–SMAD2/3–GPX4 axis, suppressing both autophagy and ferroptosis to drive tumor progression. Inhibiting UCHL5 disrupted this axis, restored autophagy–ferroptosis crosstalk, and inhibited tumor growth. The ZIF-8@1,6-HD@UCHL5-IN-1 nanoplatform targeted this pathway, induced ferroptosis, and suppressed TNBC growth safely in vivo. We identify a UCHL5–ALK5–LLPS axis that confers ferroptosis resistance in TNBC. Targeting this axis with a designed nanoplatform represents a promising dual-pathway therapeutic strategy against treatment resistance.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $3,790
OpenAlex ID: W4413449314
FWCI:
Cites: 52
Cited by:
Related to: 8